Ad is loading...
MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.

ARTH Arch Therapeutics, Inc. Forecast, Technical & Fundamental Analysis

Industry Biotechnology
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Ad is loading...
A.I. Advisor
published Earnings

ARTH is expected to report earnings to fall 20,100.00% to $2.00 per share on March 01

Arch Therapeutics, Inc. ARTH Stock Earnings Reports
Q4'22
Est.
$2.00
Q3'22
Est.
$-0.01
Q2'22
Beat
by $0.01
Q1'22
Beat
by $0.01
The last earnings report on November 30 showed earnings per share of 0 cents, meeting the estimate of 0 cents. With 1.46K shares outstanding, the current market capitalization sits at 1.15M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
235 Walnut Street
Phone
+1 617 431-2313
Employees
8
Web
https://www.archtherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SIIIX16.73-0.01
-0.06%
AlphaCentric Real Income I
CFVLX35.23-0.09
-0.25%
Commerce Value
AUENX25.67-0.33
-1.27%
AQR Large Cap Defensive Style N
AGRDX61.57-1.41
-2.24%
American Century Growth R6
RMQAX605.30-29.23
-4.61%
Rydex Monthly Rbl NASDAQ-100® 2x Strt A

ARTH and Stocks

Correlation & Price change

A.I.dvisor tells us that ARTH and EDSA have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARTH and EDSA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTH
1D Price
Change %
ARTH100%
+3.60%
EDSA - ARTH
21%
Poorly correlated
-4.55%
HRMY - ARTH
20%
Poorly correlated
+0.65%
BIVI - ARTH
13%
Poorly correlated
+0.31%
APLIF - ARTH
12%
Poorly correlated
+2.41%
BETRF - ARTH
5%
Poorly correlated
-8.18%
More